Myasthenia gravis experimentally induced with muscle-specific kinase

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 93-98

  Shigemoto, Kazuhiro ^a,b   Kubo, Sachiho ^b   Jie, Chen ^a   Hato, Naohito ^a   Abe, Yasuhito ^a   Ueda, Norifumi ^a   Kobayashi, Naoto ^a   Kameda, Kenji ^c   Mominoki, Katsumi ^d   Miyazawa, Atsuo ^e   Ishigami, Akihito ^b   Matsuda, Seiji ^a   Maruyama, Naoki ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c EHIME UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e RIKEN HARIMA INSTITUTE   (Japan)

Author keywords

Acetylcholine receptor (AChR); Congenital myasthenic syndromes (CMS); Experimental autoimmune MG (EAMG); Muscle specific kinase (MuSK); Myasthenia gravis (MG); Neuromuscular junction (NMJ)

Indexed keywords

AGRIN; AUTOANTIBODY; CHOLINERGIC RECEPTOR; MUSCLE SPECIFIC KINASE; PHOSPHOTRANSFERASE; RAPSYN;

CONFERENCE PAPER; IN VITRO STUDY; IN VIVO STUDY; MOTONEURON; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOTUBE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PATHOGENESIS; POSTSYNAPTIC MEMBRANE; PROTEIN EXPRESSION; RABBIT; SYNAPSE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 45249083240     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.002     Document Type: Conference Paper

References (44)

1. Hoch, W., J. McConville, S. Helms, et al. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 : 365 368.
2. Lindstrom, J. 2004. Is "seronegative" MG explained by autoantibodies to MuSK? Neurology 62 : 1920 1921.
3. Selcen, D., T. Fukuda, X.M. Shen & A.G. Engel. 2004. Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 62 : 1945 1950.
4. Patrick, J. & J. Lindstrom. 1973. Autoimmune response to acetylcholine receptor. Science 180 : 871 872.
5. Ganju, P., E. Walls, J. Brennan & A.D. Reith. 1995. Cloning and developmental expression of Nsk2, a novel receptor tyrosine kinase implicated in skeletal myogenesis. Oncogene 11 : 281 290.
6. Valenzuela, D.M., T.N. Stitt, P.S. DiStefano, et al. 1995. Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 15 : 573 584.
7. DeChiara, T.M., D.C. Bowen, D.M. Valenzuela, et al. 1996. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85 : 501 512.
8. Chevessier, F., B. Faraut, A. Ravel-Chapuis, et al. 2004. MUSK, a new target for mutations causing congenital myasthenic syndrome. Hum. Mol. Genet. 13 : 3229 3240.
9. Kong, X.C., P. Barzaghi & M.A. Ruegg. 2004. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep. 5 : 183 188.
10. Vincent, A. 2002. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2 : 797 804.
11. Vincent, A., J. Bowen, J. Newsom-Davis & J. McConville. 2003. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol. 2 : 99 106.
12. Evoli, A., P.A. Tonali, L. Padua, et al. 2003. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 : 2304 2311.
13. Sanders, D.B., K. El-Salem, J.M. Massey, et al. 2003. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60 : 1978 1980.
14. Yeh, J.H., W.H. Chen, H.C. Chiu & A. Vincent. 2004. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology 62 : 2131 2132.
15. Ohta, K., K. Shigemoto, S. Kubo, et al. 2004. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG. Neurology 62 : 2132 2133.
16. Ohta, K., K. Shigemoto, S. Kubo, et al. 2005. MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase. Neurology 65 : 1988.
17. Vincent, A., J. McConville, M.E. Farrugia, et al. 2003. Antibodies in myasthenia gravis and related disorders. Ann. N.Y. Acad. Sci. 998 : 324 335.
18. Bartoccioni, E., F. Scuderi, G.M. Minicuci, et al. 2006. Anti-MuSK antibodies: correlation with myasthenia gravis severity. Neurology 67 : 505 507.
19. Deymeer, F., O. Gungor-Tuncer, V. Yilmaz, et al. 2007. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 68 : 609 611.
20. Conti-Fine, B.M., M. Milani & H.J. Kaminski. 2006. Myasthenia gravis: past, present, and future. J. Clin. Invest. 116 : 2843 2854.
21. Vincent, A., B. Lang & K.A. Kleopa. 2006. Autoimmune channelopathies and related neurological disorders. Neuron 52 : 123 138.
22. Toyka, K.V., D.B. Drachman, D.E. Griffin, et al. 1977. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N. Engl. J. Med. 296 : 125 131.
23. Shigemoto, K., S. Kubo, N. Maruyama, et al. 2006. Induction of myasthenia by immunization against muscle-specific kinase. J. Clin. Invest. 116 : 1016 1024.
24. Scuderi, F., M. Marino, L. Colonna, et al. 2002. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement. Lab. Invest. 82 : 1139 1146.
25. Jha, S., K. Xu, T. Maruta, M. Oshima, et al. 2006. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J. Neuroimmunol. 175 : 107 117.
26. Ruegg, M.A., K.W. Tsim, S.E. Horton, et al. 1992. The agrin gene codes for a family of basal lamina proteins that differ in function and distribution. Neuron 8 : 691 699.
27. Glass, D.J., D.C. Bowen, T.N. Stitt, et al. 1996. Agrin acts via a MuSK receptor complex. Cell 85 : 513 523.
28. Cohen, I., M. Rimer, T. Lomo & U.J. McMahan. 1997. Agrin-induced postsynaptic-like apparatus in skeletal muscle fibers in vivo. Mol. Cell Neurosci. 9 : 237 253.
29. Ferns, M., M. Deiner & Z. Hall. 1996. Agrin-induced acetylcholine receptor clustering in mammalian muscle requires tyrosine phosphorylation. J. Cell. Biol. 132 : 937 944.
30. Lin, W., R.W. Burgess, B. Dominguez, et al. 2001. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410 : 1057 1064.
31. Yang, X., S. Arber, C. William, et al. 2001. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron 30 : 399 410.
32. Akaaboune, M., S.M. Culican, S.G. Turney & J.W. Lichtman. 1999. Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo. Science 286 : 503 507.
33. Akaaboune, M., R.M. Grady, S. Turney, et al. 2002. Neurotransmitter receptor dynamics studied in vivo by reversible photo-unbinding of fluorescent ligands. Neuron 34 : 865 876.
34. Gautam, M., T.M. DeChiara, D.J. Glass, et al. 1999. Distinct phenotypes of mutant mice lacking agrin, MuSK, or rapsyn. Brain Res. Dev. Brain Res. 114 : 171 178.
35. Burgess, R.W., Q.T. Nguyen, Y.J. Son, et al. 1999. Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron 23 : 33 44.
36. Gautam, M., P.G. Noakes, L. Moscoso, et al. 1996. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85 : 525 535.
37. Sanes, J.R. & J.M. Cheney. 1982. Lectin binding reveals a synapse-specific carbohydrate in skeletal muscle. Nature 300 : 646 647.
38. Sugiyama, J.E., D.J. Glass, G.D. Yancopoulos & Z.W. Hall. 1997. Laminin-induced acetylcholine receptor clustering: an alternative pathway. J. Cell. Biol. 139 : 181 191.
39. Martin, P.T. & J.R. Sanes. 1995. Role for a synapse-specific carbohydrate in agrin-induced clustering of acetylcholine receptors. Neuron 14 : 743 754.
40. Marangi, P.A., S.T. Wieland & C. Fuhrer. 2002. Laminin-1 redistributes postsynaptic proteins and requires rapsyn, tyrosine phosphorylation, and Src and Fyn to stably cluster acetylcholine receptors. J. Cell. Biol. 157 : 883 895.
41. McConville, J., M.E. Farrugia, D. Beeson, et al. 2004. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann. Neurol. 55 : 580 584.
42. Okada, K., A. Inoue, M. Okada, et al. 2006. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312 : 1802 1805.
43. Beeson, D., O. Higuchi, J. Palace, et al. 2006. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 313 : 1975 1978.
44. Palace, J., D. Lashley, J. Newsom-Davis, et al. 2007. Clinical features of the DOK7 neuromuscular junction synaptopathy. Brain 130 : 1507 1515.